Nomura Securities initiates coverage on Infinity Pharmaceutical (NASDAQ: INFI) with a Neutral. PT $14.00.

Analyst Ian Somaiya comments: "Infinity ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE